Replies to post #45151 on RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Exactly.

They have progressed into tier 3 preclinicals with the NIH to mitigate the opioid epidemic. This positive progression is valuable and important. It is only logical that monied interests and big pharma are watching these trials closely. IMO, if these trials confirm their past preclinical observations that lead into human clinicals, than the sky is the limit as to how valuable this drug development program has become.... IMO.